Pursuant to Regulations 30 and 47 of SEBI(LODR) Regulations, 2015, we are forwarding herewith copies of Newspaper clippings regarding Audited Consolidated & Standalone Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TCM Limited (formerly Travancore Chemical & Mfg. Co. Ltd.) has published its audited financial results for Q4 and full year FY26 ended 31 March 2026. Standalone revenue declined to Rs 1,853.27 lakhs from Rs 2,950.82 lakhs in FY25, while the company swung to a net loss of Rs 362.56 lakhs versus profit of Rs 314.92 lakhs previously. Consolidated figures show an even larger loss of Rs 599.25 lakhs on revenue of Rs 2,069.49 lakhs. Basic EPS stood at Rs (4.85) for standalone and Rs (7.78) for consolidated, reflecting significant deterioration in profitability year-on-year. The results were published on 27 May 2026 in Financial Express and Deepika newspapers.
The company has reported a sharp turnaround from profit to substantial losses with nearly 37% revenue decline, indicating serious operational challenges. Shareholders should note the dramatic worsening of financial performance compared to FY25.